ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Biogen Inc

Biogen Inc (IDP)

150.35
-0.90
(-0.60%)
Closed November 26 3:00PM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
150.35
Bid
150.00
Ask
150.85
Volume
891
149.05 Day's Range 152.60
0.00 52 Week Range 0.00
Market Cap
Previous Close
151.25
Open
150.75
Last Trade
4
@
150.35
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
145,719,340
Dividend Yield
-
PE Ratio
19.79
Earnings Per Share (EPS)
7.97
Revenue
9.84B
Net Profit
1.16B

About Biogen Inc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker IDP. The last closing price for Biogen was 151.25 €. Over the last year, Biogen shares have traded in a share price range of 0.00 € to 0.00 €.

Biogen currently has 145,719,340 shares outstanding. The market capitalization of Biogen is 22.04 € billion. Biogen has a price to earnings ratio (PE ratio) of 19.79.

IDP Latest News

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity Dapirolizumab pegol (DZP) met its...

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd...

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference -New testing method highlights link...

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases The collaboration aims to...

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as...

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025 Robin Kramer, Chief Accounting Officer, to Succeed HimCAMBRIDGE, Mass., Oct. 28, 2024 (GLOBE...

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 The detailed study results confirmed interim...

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference CAMBRIDGE, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB...

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024 Late breaker oral presentation to feature final results of the Phase 2 IGNAZ study...

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients Designation is based on data from the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
2RZPoseida Therapeutics Inc
8.90 €
(225.77%)
48.28k
GMEGeratherm Medic
5.55 €
(83.77%)
91.55k
7S2Scotch Creek Ventures Inc
0.0144 €
(67.44%)
100k
ZN80Hesai Group
7.20 €
(59.29%)
37.64k
AXIAtos SE
0.595 €
(57.62%)
3.04M
CHPCitigold Corporation Ltd
0.001 €
(-60.00%)
250k
L7C2Windfall Geotek Inc
0.0025 €
(-54.55%)
500
QN90Military Metals Corp
0.278 €
(-36.53%)
324.13k
PKTMPIERER Mobility AG
9.06 €
(-35.74%)
173.35k
0Z2Alector Inc
2.44 €
(-35.45%)
34.44k
R1EAEV Resources Ltd
0.002 €
(25.00%)
4.8M
D7GNel ASA
0.272 €
(1.12%)
3.14M
AXIAtos SE
0.595 €
(57.62%)
3.04M
PF8European Lithium Limited
0.0168 €
(0.00%)
2.96M
3CPXiaomi Corporation
3.2835 €
(-5.40%)
2.09M

Discussion

View Full Feed
jimmy051357 jimmy051357 2 minutes ago
It will stay expert market until Jan. 1. All will be made clear on Dec 30 on "X"
SANP
BigBadWolf BigBadWolf 2 minutes ago
DON’T LET THE DOOR HIT YOU ON THE WAY OUT…IN YOUR WEAKENED CONDITION.. Should have stayed quiet ;-) $RDARemoved
RDAREMOVED
100lbStriper 100lbStriper 2 minutes ago
that shore line looks familiar!!!
NLST
Stock_Barber Stock_Barber 3 minutes ago
This dog has fleas...


https://bettervet.com/hubfs/dog-scratching-fleas-and-ticks-off-body.png
LEEN
igotthemojo igotthemojo 3 minutes ago
i am sick to death of those bagworm posts and frankly, all the other horsesh-t he posts...in all the years that i have been on this site, i have never put anyone on ignore...but im getting close...not one gdam thing of any real interest to anyone holding kblb stock...
KBLB
k9narc k9narc 3 minutes ago
He's useful?

For what?

https://investorshub.advfn.com/uimage/uploads/2024/11/26/nijfu465706526_1036870611782792_1533520707267672408_n.jpg
sab63090 sab63090 3 minutes ago
Good call, Tom! I see you are remaining/leaning to a bearish outcome & even though I did NOT get this right, I'm still thinking the the momentum is not entirely lost, so I remain bullish and will wait this out....back to my closet...cheers!
AVXL
crazy horse 0 crazy horse 0 3 minutes ago
Nate Cohn: The Democratic Party is in Trouble

In contrast, the only group that has moved significantly toward Democrats is white Americans with a college degree (+17). What Trump has done here came as a real shock to Democrats.


https://media.townhall.com/cdn/h
SPARK SPARK 3 minutes ago
Ahh..Great! I like that stock~
waterchaser waterchaser 3 minutes ago
I've proven time and time again that this HIRU Board is infested with scam pumpers attempting to dupe the less informed into buying their worthless shares. It's a despicable practice IMO.
End of story.

https://investorshub.advfn.com/uimage/uploads/2016/7/17/emfctIHUB_Profile.j
HIRU
glenn1919 glenn1919 4 minutes ago
IFBD............................................a/h
IFBD
IB_ IB_ 4 minutes ago
My Daddy has made millions with ELTP over the years ...........

He doesn't post on any ELTP boards but if he did, he told me he would call himself, "Dad of IB_🤴" ..............

Why are you here ????

Bet ya can't say,

IB_🤴
ELTP
lakers17 lakers17 4 minutes ago
PIN I just bought last week at .178 is now .80
Jimmy99er Jimmy99er 4 minutes ago
That would explain a lot then...lol
CBDY
nwsun nwsun 5 minutes ago
Can any of you tell which market maker(s) is instigating these trades?
SFLM
ANTI-BAGHOLDER ANTI-BAGHOLDER 6 minutes ago
Very excited to have announced, earlier today, that @mroctober , Reggie Jackson, has joined our Board of Advisors. Thank you for joining us, Reggie!

MONI
MONI
Bizreader Bizreader 6 minutes ago
Now we know that you're lying. 
COOP
Zorax Zorax 6 minutes ago
Question to the board.
If orangedonshittypants goes into a coma with no active brainwaves - (a difficult thing to track of his in the first place) does that hand it off to vance.
Or because no one is sworn in, shouldn't it go to Harris as the runner up candidate?

I'm ge
sab63090 sab63090 6 minutes ago
Kentucky:

Yes that's a plus; and after seeing the close today and being slapped on my earlier bullish impressions, the close wasn't too bad either.
AVXL
Bizreader Bizreader 6 minutes ago
This pretty much calls it like it is and settles a lot of these ridiculous debates. 
COOP
Golden Cross Golden Cross 6 minutes ago
$ILLR ~ Triller A Social Media Disruptor
https://youtube.com/watch?v=ZZJpMq5lusE

[yt]ZZJpMq5lusE[/yt]
ILLR
rmmc rmmc 7 minutes ago
Here is a fact for you , 15 years on this board and never have you been able to prove HIRU is a scam. Not 1 shred of evidence. I play the ups and downs here and HIRU pays off even when it seems like a scam. But nobody can prove it is and the same comments over and over are weak and meaningless
HIRU
SPARK SPARK 7 minutes ago
Michael's younger brother~
Golden Cross Golden Cross 8 minutes ago
$ILLR ~ Triller A Social Media Disruptor
https://youtube.com/watch?v=ZZJpMq5lusE

[yt]ZZJpMq5lusE[/yt]
ILLR

Your Recent History

Delayed Upgrade Clock